Octadecanedioic acid

CAS No. 871-70-5

Octadecanedioic acid( —— )

Catalog No. M26346 CAS No. 871-70-5

Octadecanedioic acid is an endogenous metabolite, is a long-chain dicarboxylic acid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 31 In Stock
1G 43 In Stock

Biological Information

  • Product Name
    Octadecanedioic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Octadecanedioic acid is an endogenous metabolite, is a long-chain dicarboxylic acid.
  • Description
    Octadecanedioic acid is an endogenous metabolite, is a long-chain dicarboxylic acid.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    PHGDH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    871-70-5
  • Formula Weight
    314.466
  • Molecular Formula
    C18H34O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (318.01 mM)
  • SMILES
    OC(=O)CCCCCCCCCCCCCCCCC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rohde JM, et al. Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors. Bioorg Med Chem. 2018 May 1;26(8):1727-1739.
molnova catalog
related products
  • Ternidazole hydrochl...

    Ternidazole hydrochloride (Ternidazole HCl) is a 5-nitroimidazole antibiotic with antimicrobial antioxidant and antiprotozoal activity.

  • L-Methionine sulfoxi...

    L-Methionine sulfoxide (H-Met(O)-OH) is a metabolite of Methionine. (H-Met(O)-OH) modulates oxidative stress and purinergic signaling parameters, and induces M1/classical macrophage polarization.

  • DL-3-AMINOISOBUTYRIC...

    beta-aminoisobutyric acid is the product from the conversion of N-carbamyl-beta-aminoisobutyric acid by the enzyme Beta-ureidopropionase (EC 3.5.1.6) the last step in pyrimidine degradation. Beta-ureidopropionase deficiency is an inborn error of pyrimidine degradation associated with neurological abnormalities.